Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide
Diabetes mellitus type 2 is a chronic progressive disease which leads to specific vascular complications - microangiopathy and macroangiopathy. These complications are the reason of increased cardiovascular mortality, which is 4-5 times higher in patients with type 2 diabetes mellitus than in the ge...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2013-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1106 |
| _version_ | 1797842060561088512 |
|---|---|
| author | N. A. Chernikova E. A. Ermakova |
| author_facet | N. A. Chernikova E. A. Ermakova |
| author_sort | N. A. Chernikova |
| collection | DOAJ |
| description | Diabetes mellitus type 2 is a chronic progressive disease which leads to specific vascular complications - microangiopathy and macroangiopathy. These complications are the reason of increased cardiovascular mortality, which is 4-5 times higher in patients with type 2 diabetes mellitus than in the general population. |
| first_indexed | 2024-04-09T16:40:58Z |
| format | Article |
| id | doaj.art-bbdc1f1db45f41b99a7687213c164a62 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:40:58Z |
| publishDate | 2013-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-bbdc1f1db45f41b99a7687213c164a622023-04-23T06:56:41ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-0109707510.21518/2079-701X-2013-9-70-751106Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamideN. A. Chernikova0E. A. Ermakova1the Russian Medical Academy of Postgraduate Educationthe Russian Medical Academy of Postgraduate EducationDiabetes mellitus type 2 is a chronic progressive disease which leads to specific vascular complications - microangiopathy and macroangiopathy. These complications are the reason of increased cardiovascular mortality, which is 4-5 times higher in patients with type 2 diabetes mellitus than in the general population.https://www.med-sovet.pro/jour/article/view/1106diabetes mellitusvascular complicationsantihyperglycemic drugsglibenclamideсахарный диабетсосудистые осложнениясахароснижающие препаратыглибенкламид |
| spellingShingle | N. A. Chernikova E. A. Ermakova Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide Медицинский совет diabetes mellitus vascular complications antihyperglycemic drugs glibenclamide сахарный диабет сосудистые осложнения сахароснижающие препараты глибенкламид |
| title | Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide |
| title_full | Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide |
| title_fullStr | Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide |
| title_full_unstemmed | Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide |
| title_short | Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide |
| title_sort | аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide |
| topic | diabetes mellitus vascular complications antihyperglycemic drugs glibenclamide сахарный диабет сосудистые осложнения сахароснижающие препараты глибенкламид |
| url | https://www.med-sovet.pro/jour/article/view/1106 |
| work_keys_str_mv | AT nachernikova anoverviewofcardiovascularrisksinpatientswithtype2diabetesreceivingglibenclamide AT eaermakova anoverviewofcardiovascularrisksinpatientswithtype2diabetesreceivingglibenclamide |